Patients with Metastatic Colorectal Cancer after Failure of Second-Line Treatment May Benefit from Low-Dose Apatinib and S-1 Combined with Jianpi Bushen Jiedu Decoction

OBJECTIVE: To evaluate the effect and safety of low-dose of apatinib and S-1 combined with Jianpi Bushen Jiedu Decoction (JBJD) in patients with metastatic colorectal cancer (mCRC) who have failed second or above lines treatment, in order to provide more treatment option for mCRC patients by integra...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yue, Xu, Yu-ying, Jiang, Hai-jun, Wang, Lei, Zhai, Jia-wei, Zhang, Tong, Yang, Yu-fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Clinical Experience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068502/
https://www.ncbi.nlm.nih.gov/pubmed/35508862
http://dx.doi.org/10.1007/s11655-022-3676-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068502/
https://www.ncbi.nlm.nih.gov/pubmed/35508862
http://dx.doi.org/10.1007/s11655-022-3676-7

Ejemplares similares